Document:

EX-10.5

EXHIBIT 10.5

NEWELL RUBBERMAID INC. 2003 STOCK PLAN

(As Amended and Restated Effective February 8, 2006

and further amended August 9, 2006))

RESTRICTED STOCK AWARD AGREEMENT

A Restricted Stock Award (the “Award”) granted by Newell Rubbermaid Inc., a Delaware
corporation (the “Company”), to the employee named in the attached Award letter (the “Grantee”), of
common stock, par value $1.00 per share and related common stock purchase rights (the “Common
Stock”), of the Company, shall be subject to the following terms and conditions and the provisions
of the Newell Rubbermaid Inc. 2003 Stock Plan, as amended and restated effective February 8, 2006
and further amended August 9, 2006 (the “Plan”), a copy of which is attached hereto and the terms
of which are hereby incorporated by reference:

1. Acceptance by Grantee. The receipt of the Award is conditioned upon its acceptance
by the Grantee in the space provided therefor at the end of the attached Award letter and the
return of an executed copy of such Award letter to the Secretary of the Company no later than 60
days after the Award Date set forth therein or, if later, 30 days after the Grantee receives this
Agreement.

2. Transfer Restrictions. None of the shares of Common Stock subject to the Award
(“Award Shares”) shall be sold, assigned, pledged or otherwise transferred, voluntarily or
involuntarily, by the Grantee (or his estate or personal representative, as the case may be), until
such restrictions lapse in accordance with Sections 3 and 4 below.

3. Lapse of Restrictions. The restrictions set forth in Section 2 above shall lapse
on the third anniversary of the Award Date with respect to all of the Award Shares.

4. Death, Disability or Retirement. To the extent the restrictions set forth in
Section 2 have not lapsed in accordance with Section 3, in the event that the Grantee’s employment
with the Company and all affiliates terminates due to the Grantee’s death, disability or
retirement, such restrictions shall lapse on the date of such termination. For this purpose (i)
“disability” means (as determined by the Committee in its sole discretion) the inability of the
Grantee to engage in any substantial gainful activity by reason of any medically determinable
physical or mental impairment which is expected to result in death or disability or which has
lasted or can be expected to last for a continuous period of not less than 12 months; and (ii)
“retirement” means termination of the Grantee’s employment for any reason other than cause (as
determined by the Company in its sole discretion) on or after the Grantee’s attainment age of 65.

5. Forfeiture. Subject to the next following sentence, the Award shall be forfeited
to the Company upon the Grantee’s termination of employment with the Company and all affiliates for
any reason other than the Grantee’s death, disability or retirement (as described in Section 4
above) that occurs prior to the date the restrictions lapse as provided in Section 3 above. The
foregoing provisions of this Section 5 shall be subject to the provisions of any written employment
security agreement or severance agreement that has been or may be executed by the Grantee and the
Company, and the provisions in such employment security agreement or severance agreement concerning
the lapse of restrictions of an Award in connection with the Grantee’s termination of employment
shall supercede any inconsistent or contrary provision of this Section 5.

6. Withholding Taxes. If applicable, the Grantee shall pay to the Company an amount
sufficient to satisfy all minimum Federal, state and local withholding tax requirements prior to
the delivery of any certificate for Award Shares. Payment of such taxes may be made by one or more
of the following methods: (i) in cash, (ii) in cash received from a broker-dealer to whom the
Grantee has submitted irrevocable instructions to deliver the amount of withholding tax to the
Company from the proceeds of the sale of shares subject to the Award, (iii) by delivery to the
Company of other Common Stock owned by the Grantee that is acceptable to the Company, valued at its
Fair Market Value on the date of payment, or (iv) by certifying to ownership by attestation of such
previously owned Common Stock.

7. Rights as Stockholder. The Grantee shall be entitled to all of the rights of a
stockholder of the Company with respect to the Award Shares, including the right to vote such
shares and to receive dividends and other distributions payable with respect to such Award Shares
from the Award Date.

8. Share Delivery. Delivery of the Award Shares will be by book-entry credit to an
account in the Grantee’s name established by the Company with the Company’s transfer agent. On the
date the restrictions lapse with respect to the Award, and provided that the Grantee has complied
with all obligations and conditions set forth in the Plan and this Agreement, the Company shall,
upon written request from the Grantee (or his estate or personal representative, as the case may
be), issue certificates in the name of the Grantee (or his estate or personal representative)
representing such Award Shares.

9. Section 83(b) Election. The Grantee may make an election pursuant to Section 83(b)
of the Internal Revenue Code to recognize income with respect to the Award Shares before the
restrictions lapse, by filing such election with the Internal Revenue Service within 30 days of the
Award Date and providing a copy of that filing to the Company.

10. Administration. The Award shall be administered in accordance with such
regulations as the Organizational Development and Compensation Committee of the Board of Directors
of the Company (the “Committee”) shall from time to time adopt.

11. Governing Law. This Agreement, and the Award, shall be construed, administered
and governed in all respects under and by the laws of the State of Delaware.

IN WITNESS WHEREOF, this Agreement is executed by the Company this      th day of      ,
     , effective as of the      day of      ,      .

NEWELL RUBBERMAID INC.

By:

CH2\2313153.1EX-10.1

Exhibit 10.1

STOCK OPTION AGREEMENT (this “Agreement”) dated as of      , 200     (the
“Grant Date”), between Nastech Pharmaceutical Company Inc., a Delaware corporation (the
“Company”), and      (Grantee”), an employee of the Company.

SECTION 1. Grant of Option. Pursuant to the Nastech Pharmaceutical Company Inc.
     (the “Plan”), the Company hereby grants to Grantee, as of the Grant Date, a
Stock Option, to purchase an aggregate of                  shares (the “Option Shares”) of
common stock of the Company, par value $0.006 per share (the “Common Stock”), at an
exercise price of $    per share (the “Option”) subject to adjustment and the other
terms and conditions set forth herein, in the Plan. Notwithstanding any provision of this
Agreement to the contrary, if there is any conflict between the provisions of this Agreement and
the employment agreement entered into by the Grantee and the Company (the “Employment Agreement”),
the provision of the Employment Agreement shall control.

SECTION 2. Grantee Bound by Plan. The Plan is incorporated herein by reference and
made a part hereof. The Plan shall govern all aspects of this Agreement except as otherwise
specifically stated herein. Grantee hereby acknowledges receipt of a copy of the Plan and agrees
to be bound by all the terms and provisions thereof. Unless otherwise defined herein, capitalized
terms used but not defined herein shall have the meanings ascribed to them in the Plan. The Plan
should be carefully examined before any decision is made to exercise this Option.

SECTION 3. Exercise of Option.

(a) General. Subject to the earlier termination of the Option as provided herein and in the
Plan, the Option may be exercised by written notice to the Company at any time and from time to
time after the Grant Date; provided, however, that the Option shall not be
exercisable for more than the number of shares which are vested in accordance herewith at the time
of exercise. The exercise of this Option and the issuance of Option Shares upon such exercise
shall be subject to compliance by the Company and Grantee with all applicable requirements of law
as set forth in the Plan. The inability of the Company to obtain approval from any regulatory body
having authority deemed by the Company to be necessary to the lawful issuance and sale of any
Common Stock pursuant to this Option shall relieve the Company of any liability with respect to the
non-issuance or sale of the Common Stock as to which such approval shall not have been obtained.

(b) Vesting. Subject to the earlier termination of the Option as provided herein and in the
Plan, the Option shall vest as follows:

	 	 	 
	1/3

	 	Of the shares subject to the Option shall be vested on

     
	 

	 	 
	1/3

	 	Of the shares subject to the Option shall be vested on

     
	 

	 	 
	1/3

	 	Of the shares subject to the Option shall be vested on

     
	 

	 	 

(c) Early Expiration of Option. (i) Upon the termination of Grantee’s employment or
consulting relationship with the Company (including any subsidiary thereof) for any reason,
including death, any portion of the Option granted hereunder that has not been exercised on the
date of such termination shall expire in accordance with subsection (ii) or (iii)of this Section
3(c) as applicable.

(ii) In the event that Grantee’s employment or consulting relationship with the Company
(including any subsidiary thereof) is terminated by the Company for Cause, Grantee shall
automatically forfeit his right to exercise any portion of the Option granted hereunder that has
not been exercised as of the date of such termination without regard to whether such portion of the
Option had previously vested and such unexercised portion of the Option shall automatically be
cancelled effective at the commencement of business on the date of such termination.

(iii) In the event that Grantee’s employment or consulting relationship with the Company
(including any subsidiary thereof) is terminated for any reason other than for Cause, death, or
Disability, any unvested portion of the Option granted hereunder shall immediately expire and any
vested portion of the Option granted hereunder that has not been exercised as of the date of such
termination shall automatically expire, if not exercised beforehand, three months after such
termination.

(iv) In the event that Grantee’s employment or consulting relationship with the Company
(including any subsidiary thereof) is terminated due to Grantee’s death or Disability, any unvested
portion of the Option granted hereunder shall immediately expire and any vested portion of the
Option granted hereunder that has not been exercised as of the date of such termination shall
automatically expire, if not exercised beforehand, three months after such termination.

(d) Normal Expiration of Option. This Option shall not be exercisable after the tenth
anniversary of the Grant Date (the “Expiration Date”).

SECTION 4. Exercise of Option and Conditions to Exercise. This Option may not be
exercised by Grantee unless the following conditions are met:

(a) Notice. This Option shall be exercised by delivering written notice, substantially in the
form attached hereto as Exhibit I, to the Company at its principal office addressed to the
attention of its Secretary. Such notice shall specify the number of Option Shares with respect to
which the Option is being exercised and shall be signed by Grantee. This Option may not be
exercised for a fraction of a share of Common Stock;

(b) Securities Requirements. Legal counsel for the Company must be satisfied at the time of
exercise that the issuance of Option Shares upon exercise will be in compliance with the Securities
Act of 1933, as amended (the “Securities Act”), and applicable United States federal, state, local
and foreign laws; and

(c) Payment of Exercise Price. Grantee must pay at the time of exercise the full purchase
price for the shares of Common Stock being acquired hereunder (i) in cash or its equivalent or (ii)
pursuant to such other method as the Committee may approve from time to time. Please refer to the
Plan for a complete description of the methods for exercise, payment and delivery of Option Shares,
including requirements for the payment of withholding taxes applicable thereto.

SECTION 5. Transferability. This Option may not be sold, assigned, transferred,
pledged, hypothecated or otherwise disposed of by Grantee, except by will or the laws of descent
and distribution (in which case, the transferee shall succeed to the rights and obligations of
Grantee hereunder) and is exercisable during Grantee’s lifetime only by Grantee or his guardian or
legal representative. If Grantee or anyone claiming under or through Grantee attempts to violate
this Section 5, such attempted violation shall be null and void and without effect, and the
Company’s obligation hereunder shall terminate. If at the time of Grantee’s death this Option has
not been fully exercised, Grantee’s estate or any person who acquires the right to exercise this
Option by bequest or inheritance or by reason of Grantee’s death may exercise this Option in
accordance with and with respect to the number of shares set forth in Section 3 above. The
applicable requirements of Section 4 above must be satisfied in full at the time of any exercise.

SECTION 6. Administration. Any action taken or decision made by the Company, the
Board or the Committee or its delegates arising out of or in connection with the construction,
administration, interpretation or effect of the Plan or this Agreement shall lie within its sole
and absolute discretion, as the case may be, and shall be final, conclusive and binding on Grantee
and all persons claiming under or through Grantee. By accepting this grant or other benefit under
the Plan, Grantee and each person claiming under or through Grantee shall be conclusively deemed to
have indicated acceptance and ratification of, and consent to, any action taken under the Plan by
the Company, the Board or the Committee or its delegates.

SECTION 7. No Rights as Stockholder. Unless and until a certificate or certificates
representing shares of Common Stock shall have been issued to Grantee (or any person acting under
Section 5 above) pursuant to an exercise hereunder, Grantee shall not be or have any of the rights
or privileges of a stockholder of the Company with respect to shares of Common Stock acquirable
upon exercise of the Option. No adjustment shall be made for cash dividends or other rights for
which the record date is prior to the date of such due exercise and full payment.

SECTION 8. Investment Representation. Grantee hereby acknowledges that the Option
Shares shall be acquired for investment without a view to distribution, within the meaning of the
Securities Act, and shall not be sold, transferred, assigned, pledged or hypothecated in the
absence of an effective registration statement for the shares of Common Stock under the Securities
Act and applicable states securities laws or an applicable exemption from the registration
requirements of the Securities Act and any applicable state securities laws. Grantee also agrees
that the Option Shares will not be sold or otherwise disposed of in any manner which would
constitute a violation of any applicable securities laws, whether federal or state and that the
certificate representing the shares of Common Stock shall contain a legend to such effect.

SECTION 9. Listing and Registration of Common Stock. The Company, in its discretion,
may postpone the issuance and/or delivery of shares of Common Stock upon any exercise of this
Option until completion of such stock exchange listing, or registration, or other qualification of
such shares under any state and/or federal law, rule or regulation as the Company may reasonably in
good faith consider appropriate.

SECTION 10. Adjustments. (a) Anti-Dilution. In the event of any change in the number
of shares of Common Stock outstanding by reason of any stock dividend or split, reverse stock
split, capitalization, merger, consolidation or otherwise, the Committee shall make appropriate
adjustment to the number of Option Shares granted hereunder and the exercise price thereof in order
to preserve the position of Grantee and prevent any enlargement or dilution of such position.

(b) Certain Transactions. In the event of the proposed dissolution or liquidation of the
Company, all Options will terminate immediately prior to the consummation of such proposed action,
unless otherwise provided by the Committee. The Committee may, in the exercise of its sole
discretion in such instances, declare that any Option shall terminate as of a date fixed by the
Committee and give each Grantee the right to exercise his or her Option as to all or any of the
Shares issuable pursuant to the exercise of the Option, including Shares which would not otherwise
be then issuable pursuant to the exercise of the Option. In the event of a proposed sale of all or
substantially all of the assets of the Company, or the merger of the Company with or into another
corporation, the Option shall be assumed or an equivalent option shall be substituted by such
successor corporation or a parent or subsidiary of such successor corporation, unless the Board
determines, in the exercise of its sole discretion and in lieu of such assumption or substitution,
that the Grantee shall have the right to exercise the Option in whole or in part, including Shares
which would not otherwise be then issuable pursuant to the exercise of the Option. If the Board
makes an Option exercisable in lieu of assumption or substitution in the event of a merger or sale
of assets, the Board shall notify the Grantee that the Option shall be exercisable for a period of
not less than 15 days from the date of such notice, and the Option will terminate upon the
expiration of such period..

SECTION 11. Notices. Any notice hereunder to the Company shall be addressed to the
Company at 3830 Monte Villa Parkway, Bothell, WA 98021, Attention: Secretary, and any notice
hereunder to Grantee shall be addressed to Grantee at Grantee’s last address on the records of the
Company, subject to the right of either party to designate at any time hereafter in writing some
other address. Any notice shall be deemed to have been duly given when delivered personally, one
day following dispatch if sent by reputable overnight courier, fees prepaid, or three days
following mailing if sent by registered mail, return receipt requested, postage prepaid and
addressed as set forth above.

SECTION 12. Binding Effect. This Agreement shall be binding upon and inure to the
benefit of any successors to the Company and all persons lawfully claiming under Grantee.

SECTION 13. Governing Law. The validity, construction, interpretation, administration
and effect of the Plan, and of its rules and regulations, and rights relating to the Plan and to
this Agreement, shall be governed by the substantive laws, but not the choice of law rules, of the
State of Delaware.

IN WITNESS WHEREOF, the Company and Grantee have executed this Agreement as of the date first
above written.

NASTECH PHARMACEUTICAL COMPANY INC.

     

     

GRANTEE ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE OPTION IS EARNED ONLY
THROUGH HIS CONTINUED AND SATISFACTORY EMPLOYMENT WITH THE COMPANY OR ITS SUBSIDIARIES AND NOT
THROUGH THE GRANT OF THIS OPTION OR THE ACQUISITION OF SHARES HEREUNDER. GRANTEE ACKNOWLEDGES AND
AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE COMPANY’S      PLAN WHICH IS
INCORPORATED HEREIN BY REFERENCE, SHALL CONFER UPON GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION
OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY WITH HIS RIGHT OR THE COMPANY’S
RIGHT TO TERMINATE HIS EMPLOYMENT AT ANY TIME, WITH OR WITHOUT CAUSE.

Grantee acknowledges receipt of a copy of the Plan and represents that he is familiar with the
terms and provisions thereof, and hereby accepts this Option subject to all of the terms and
provisions thereof except as otherwise specifically stated in this Option Agreement. Grantee has
reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice
of counsel prior to executing this Agreement and fully understands all provisions of this
Agreement. Grantee hereby agrees to accept as binding, conclusive and final all decisions or
interpretations of the Board or Committee upon any questions arising under the Plan.

GRANTEE

     

Name:      

1

EXHIBIT I

NOTICE OF EXERCISE OF STOCK OPTION

Reference is hereby made to the [Stock Option Award Agreement] (the “Award Agreement”)
dated as of      , 200     between      and Nastech Pharmaceutical Company Inc., a
Delaware corporation (the “Company”). The undersigned hereby notifies the Company that its
elect to purchase      shares of the Company’s Common Stock (the “Purchased
Shares”) at the option exercise price of $    per share (the “Exercise Price”)
pursuant to that certain option (the “Option”) granted to the undersigned on      ,
200_, to purchase up to      shares of the Company’s Common Stock.

Concurrently with the delivery of this Exercise Notice to the Secretary of the Company, the
undersigned shall hereby pay to the Company the Exercise Price for the Purchased Shares in
accordance with the provisions of the Award Agreement and shall deliver whatever additional
documents may be required by the Award Agreement as a condition for exercise.

Date:      

     

Name:

Address:      

     

     

	 	 	 	 	 
	Print name in exact manner
it is to appear on the
stock certificate:
	 	 	—	 
	Address to which certificate
is to be sent, if different
from address above:
	 	 	—	 

     

     

Social Security Number      

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]